1-3 of 3
Joachim Petit
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

BIRC5 inhibition as a novel approach to target RAS mutant and drug-resistant multiple myeloma

Free
Jeremiah Pfitzer, Joachim Petit, Harish Kumar, Razan Waliagha, Xi Chen, Adam Keeton, Yulia Maxuitenko, Zachary Davis, Kelli Gyotoku, Linda Baughn, Aimee Merino, Shaji Kumar, Gary Piazza, Taraswi Ghosh, Brian Van Ness, Amit Mitra
Journal: Blood
Blood (2025) 146 (Supplement 1): 5705.
https://doi.org/10.1182/blood-2025-5705
Published: 2025
Journal Articles

Mutant N- and K- Ras S how Distinct Effects on Growth, Signaling and Drug Response in CRISPR-Cas Edited Alleles of a Myeloma Cell Line

Free
Brian Van Ness, Amit K Mitra, Lisa Wiesen, Linda Banovic Baughn, Shaji Kunnathu Kumar, Joachim Petit, Jeremiah Pfizer, Kelli Gyotoku
Journal: Blood
Blood (2023) 142 (Supplement 1): 3320.
https://doi.org/10.1182/blood-2023-179579
Published: 2023
Journal Articles

Mathematical Models To Identify Combined Protein and Clinical Biomarkers of Response to Induction Chemotherapy in Acute Myeloid Leukemia (AML).

Free
Raoul Tibes, MD, PhD, Natalie Meurice, PhD, Steven P. Anthony, DO, YiHua Qiu, PhD, Steven M. Kornblau, MD, Spyro Mousses, PhD, Joachim Petit, PhD
Journal: Blood
Blood (2007) 110 (11): 2399.
https://doi.org/10.1182/blood.V110.11.2399.2399
Published: 2007